Alnylam has been a pioneer in hereditary ATTR amyloidosis, getting approval in 2018 for the first drug to treat the rare disease, and has now launched a digital companion to help patients track their ...
Australian National Phenome Center, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA6150, Australia Center for Computational and Systems Medicine, Health Futures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results